Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02305537 · ClinicalTrials.gov registry record · NA
Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment
A NA study of Obsessive - Compulsive Disorder and Social Anxiety Disorder, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 559
- Enrollment target
- 1
- Study location
NCT02305537: Completed NA study of Obsessive - Compulsive Disorder and Social Anxiety Disorder, sponsored by Mclean Hospital.
NCT02305537 is a NA study of Obsessive - Compulsive Disorder and Social Anxiety Disorder that has completed, run by Mclean Hospital. The registered enrollment target is 559 participants, below the 2,058-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02305537, a NA study of Obsessive - Compulsive Disorder and Social Anxiety Disorder, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 559 participants
- Enrollment target
- 1
- Study location
Study Summary
The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from admission to discharge, compared to patients on the waitlist, and whether these gains are maintained three months post-discharge. The following are included as examples of some of the study's hypotheses.
Primary Outcome
The SCAS is a 44-item self-report inventory that measures anxiety severity.
Conditions Studied
Interventions
- BEHAVIORAL McLean Anxiety Mastery Program
Study Locations (1)
Massachusetts
- McLean Hospital - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 559 participants |
| Start Date | 2014-10 |
| Est. Completion | 2024-11 |
| Phase | NA |
What the finished NCT02305537 record still lists
NCT02305537 is an interventional study that assigns participants to a tested intervention. The registered 559 participants enrollment target is mid-sized for trials with a published cap, below the 2,058-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (73% lower).
The record links to 6 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which McLean Anxiety Mastery Program is the first listed.
NCT02305537 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02305537 about?
NCT02305537 is a clinical study titled "Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment". The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from ...
What is the current status of trial NCT02305537?
This trial is currently completed. It is a NA study. The enrollment target is 559 participants. The study started on 2014-10. Estimated completion is 2024-11.
What conditions does trial NCT02305537 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Specific Phobia.
What interventions are being tested in trial NCT02305537?
The interventions under investigation include: McLean Anxiety Mastery Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02305537?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02305537 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02305537's enrollment target sits among peer trials
559 8th of 84 higher than 77 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia